MedPath

COMPARISON OF TWO METHODS IN TREATMENT OF SCARS.

Not Applicable
Conditions
Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified
Registration Number
CTRI/2022/11/047100
Lead Sponsor
supriya agarwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS AGED BETWEEN 18-35 YEARS OF AGE GROUP PRESENTING WITH FACIAL ATROPHIC ACNE SCARS AND HAVING REALISTIC EXPECTATIONS

Exclusion Criteria

1.ISOTRETINOIN USE FOR PAST THREE MONTHS.

2.ACTIVE LESIONS OF ACNE AND HERPES SIMPLEX.

3.PATIENTS WITH HISTORY OF BLEEDING DIATHESIS.

4.PATIENTS ON ORAL ANTI COAGULANTS OR ACNE INDUCING DRUGS.

5.PREGNANT WOMEN.

6.PATIENTS WITH HYPERTROPHIC SCARRING OR KELOIDAL TENDENCY.

7.SYSTEMIC ILLNESSES E.G. COLLAGEN AND VASCULAR DISEASES,UNCONTROLLED DIABETES MELLITUS, AND NEUROMUSCULAR DISORDERS.

8.PARTIENTS WITH HISTORY OF INJECTIONS OF COLLAGEN, OR OTHER INJECTABLE FILLERS WITHIN PAST 6 MONTHS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to compare the efficacy of fractional CO2 laser and microneedling, by using dermaroller with PRP in patients with facial atrophic acne scars by using Arora Swati et al. grading system before and after the treatment.Timepoint: at the end of the treatment.
Secondary Outcome Measures
NameTimeMethod
1.To assess the demographic characteristics of patients having facial atrophic acne scars. <br/ ><br>2. To assess the clinical improvement in grading of facial acne scars in both the groups. <br/ ><br>3.To determine the safety profile and compliance of fractional CO2 laser/ microneedling with PRP in facial atrophic acne scars.Timepoint: At the end of the treatment.
© Copyright 2025. All Rights Reserved by MedPath